{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:15:03Z","timestamp":1770228903804,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>The traditional treatment of rheumatoid arthritis (RA) has some side effects. We aimed to explore the effect of metformin treatment on the expression of HMGB1, cytokines, T cell subtypes and the clinical outcomes in RA patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The present prospective cohort study recruited 124 RA patients (metformin group) who were treated with metformin and conventional therapy (methotrexate, hydroxychloroquine sulfate and sulfasalazine) and 98 RA patients (conventional therapy group) who were only treated with conventional therapy. All subjects were admitted from December 2018 to December 2021 and continuous medication for 90\u00a0days. The serum high mobility group box 1 (HMGB1), tumor necrosis factor \u03b1 (TNF-\u03b1), interleukin (IL)-6, IL-1\u03b2 and C-reactive protein (CRP) levels were measured by enzyme-linked immunosorbent assay (ELISA). Flow cytometric were used to analyze the expression of CD4<jats:sup>+<\/jats:sup>and CD8<jats:sup>+<\/jats:sup>. Demographic and clinical statistics including age, body mass index (BMI), sex, course of disease, erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), visual analogue score (VAS)and disease activity score (DAS)-28 were collected.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The serum levels of HMGB1, CRP, IL-6, CD4+\u2009expression and CD4+\/CD8+\u2009ratio were significantly increased in patients with DAS-28 score\u2009\u2265\u20092.6. The serum HMGB1 and cytokines levels of metformin group declined more quickly during the study time. Pearson\u2019s analysis supported that a positive correlation existed between the HMGB1 and IL-6, TNF-\u03b1, CRP, CD4<jats:sup>+<\/jats:sup>, CD4<jats:sup>+<\/jats:sup>\/CD8<jats:sup>+<\/jats:sup>ratio, and VAS scores. HMGB1 could be a potential diagnostic biomarker for RA patients in active phase. Serum HMGB1 (95% CI 1.133\u20131.397,<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) was a factor associated with active RA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The serum HMGB1 levels were significantly increased in RA patients in active phase. The serum levels of HMGB1 and inflammatory factors and VAS scores were decreased gradually with metformin treatment. HMGB1 might act as a novel therapeutic target for RA.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40001-023-01476-x","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T03:01:28Z","timestamp":1700017288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effects of metformin therapy on HMGB1 levels in rheumatoid arthritis patients"],"prefix":"10.1186","volume":"28","author":[{"given":"Lihua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengzhi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jierou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"issue":"1","key":"1476_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6(1):1\u201314.","journal-title":"Bone Res"},{"issue":"13","key":"1476_CR2","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320(13):1360\u201372.","journal-title":"JAMA"},{"issue":"3","key":"1476_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/BOR.0b013e32832a2e16","volume":"21","author":"KP Liao","year":"2009","unstructured":"Liao KP, Alfredsson L, Karlson EW. Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol. 2009;21(3):279.","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"1476_CR4","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1136\/ard.49.12.980","volume":"49","author":"JM Hazes","year":"1990","unstructured":"Hazes JM, Dijkmans BA, Vandenbroucke JP, De Vries RR, Cats A. Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann Rheum Dis. 1990;49(12):980\u20132.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1476_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/cells9020475","volume":"9","author":"Y Ishikawa","year":"2020","unstructured":"Ishikawa Y, Terao C. The impact of cigarette smoking on risk of rheumatoid arthritis: a narrative review. Cells. 2020;9(2):475.","journal-title":"Cells"},{"issue":"6","key":"1476_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrrheum.2016.52","volume":"12","author":"T Frisell","year":"2016","unstructured":"Frisell T, Saevarsdottir S, Askling J. Family history of rheumatoid arthritis: an old concept with new developments. Nat Rev Rheumatol. 2016;12(6):335\u201343.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1476_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/03009740600718080","volume":"35","author":"JE Oliver","year":"2006","unstructured":"Oliver JE, Silman AJ. Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol. 2006;35(3):169\u201374.","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"1476_CR8","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/rheumatology\/keh199","volume":"43","author":"VPK Nell","year":"2004","unstructured":"Nell VPK, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology. 2004;43(7):906\u201314.","journal-title":"Rheumatology"},{"key":"1476_CR9","unstructured":"Benjamin O, Bansal P, Goyal A, Lappin SL. Disease modifying anti-rheumatic drugs (DMARD). 2018."},{"issue":"6","key":"1476_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/qjmed\/94.6.309","volume":"94","author":"ML Grove","year":"2001","unstructured":"Grove ML, Hassell AB, Hay EM, Shadforth MF. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. QJM. 2001;94(6):309\u201319.","journal-title":"QJM"},{"key":"1476_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","volume":"158","author":"W Wang","year":"2018","unstructured":"Wang W, Zhou H, Liu L. Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review. Eur J Med Chem. 2018;158:502\u201316.","journal-title":"Eur J Med Chem"},{"issue":"4","key":"1476_CR12","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/cells9040880","volume":"9","author":"Y-J Lin","year":"2020","unstructured":"Lin Y-J, Anzaghe M, Sch\u00fclke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells. 2020;9(4):880.","journal-title":"Cells"},{"key":"1476_CR13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.55563\/clinexprheumatol\/zn2u9h","volume":"39","author":"Y Matsuoka","year":"2020","unstructured":"Matsuoka Y, Morimoto S, Fujishiro M, Hayakawa K, Kataoka Y, Suzuki S, Ikeda K, Takamori K, Yamaji K, Tamura N. Metformin repositioning in rheumatoid arthritis. Clin Exp Rheumatol. 2020;39:763\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"1476_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/ph13090234","volume":"13","author":"T Salvatore","year":"2020","unstructured":"Salvatore T, Pafundi PC, Galiero R, Gjeloshi K, Masini F, Acierno C, Di Martino A, Albanese G, Alfano M, Rinaldi L. Metformin: a potential therapeutic tool for rheumatologists. Pharmaceuticals. 2020;13(9):234.","journal-title":"Pharmaceuticals"},{"issue":"2","key":"1476_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s40744-017-0073-3","volume":"4","author":"P Rein","year":"2017","unstructured":"Rein P, Mueller RB. Treatment with biologicals in rheumatoid arthritis: an overview. Rheumatol Ther. 2017;4(2):247\u201361.","journal-title":"Rheumatol Ther"},{"issue":"5","key":"1476_CR16","doi-asserted-by":"publisher","first-page":"C873","DOI":"10.1152\/ajpcell.00604.2020","volume":"320","author":"LP Bharath","year":"2021","unstructured":"Bharath LP, Nikolajczyk BS. The intersection of metformin and inflammation. Am J Physiol Cell Physiol. 2021;320(5):C873\u20139.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"10","key":"1476_CR17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1507\/endocrj.EJ18-0567","volume":"66","author":"J Xue","year":"2019","unstructured":"Xue J, Li X, Liu P, Li K, Sha L, Yang X, Zhu L, Wang Z, Dong Y, Zhang L. Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice. Endocr J. 2019;66(10):859\u201370.","journal-title":"Endocr J"},{"issue":"7","key":"1476_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254321","volume":"16","author":"N Yan","year":"2021","unstructured":"Yan N, Wang L, Li Y, Wang T, Yang L, Yan R, Wang H, Jia S. Metformin intervention ameliorates AS in ApoE-\/- mice through restoring gut dysbiosis and anti-inflammation. PLoS ONE. 2021;16(7): e0254321.","journal-title":"PLoS ONE"},{"issue":"23","key":"1476_CR19","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.21037\/atm-20-3042","volume":"8","author":"K-J Fan","year":"2020","unstructured":"Fan K-J, Wu J, Wang Q-S, Xu B-X, Zhao F-T, Wang T-Y. Metformin inhibits inflammation and bone destruction in collagen-induced arthritis in rats. Ann Transl Med. 2020;8(23):1565.","journal-title":"Ann Transl Med"},{"key":"1476_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fimmu.2020.00484","volume":"11","author":"H Yang","year":"2020","unstructured":"Yang H, Wang H, Andersson U. Targeting inflammation driven by HMGB1. Front Immunol. 2020;11:484.","journal-title":"Front Immunol"},{"issue":"1","key":"1476_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/JLB.3MIR1218-497R","volume":"106","author":"M Deng","year":"2019","unstructured":"Deng M, Scott MJ, Fan J, Billiar TR. Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation. J Leukoc Biol. 2019;106(1):161\u20139.","journal-title":"J Leukoc Biol"},{"key":"1476_CR22","doi-asserted-by":"publisher","first-page":"112617","DOI":"10.1016\/j.ecoenv.2021.112617","volume":"223","author":"T Zhang","year":"2021","unstructured":"Zhang T, Sun L, Wang T, Liu C, Zhang H, Zhang C, Yu L. Gestational exposure to PM2.5 leads to cognitive dysfunction in mice offspring via promoting HMGB1-NLRP3 axis mediated hippocampal inflammation. Ecotoxicol Environ Safety. 2021;223:112617.","journal-title":"Ecotoxicol Environ Safety."},{"issue":"3","key":"1476_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2021.11833","volume":"23","author":"H Zhao","year":"2021","unstructured":"Zhao H, Gu Y, Chen H. Propofol ameliorates endotoxin-induced myocardial cell injury by inhibiting inflammation and apoptosis via the PPAR\u03b3\/HMGB1\/NLRP3 axis. Mol Med Rep. 2021;23(3):1\u20131.","journal-title":"Mol Med Rep"},{"key":"1476_CR24","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.3389\/fimmu.2018.02118","volume":"9","author":"V Cecchinato","year":"2018","unstructured":"Cecchinato V, D\u2019Agostino G, Raeli L, Nerviani A, Schiraldi M, Danelon G, Manzo A, Thelen M, Ciurea A, Bianchi ME. Redox-mediated mechanisms fuel monocyte responses to CXCL12\/HMGB1 in active rheumatoid arthritis. Front Immunol. 2018;9:2118.","journal-title":"Front Immunol"},{"issue":"12","key":"1476_CR25","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1159\/000517185","volume":"182","author":"X Lu","year":"2021","unstructured":"Lu X, Gong S, Wang X, Hu N, Pu D, Zhang J, Wang Y, Luo J, An Q, Ju B. Celastrol exerts cardioprotective effect in rheumatoid arthritis by inhibiting TLR2\/HMGB1 signaling pathway-mediated autophagy. Int Arch Allergy Immunol. 2021;182(12):1245\u201354.","journal-title":"Int Arch Allergy Immunol"},{"issue":"9","key":"1476_CR26","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham Iii CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569\u201381.","journal-title":"Arthritis Rheum"},{"key":"1476_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2020.102437","volume":"83","author":"A Ganji","year":"2020","unstructured":"Ganji A, Farahani I, Khansarinejad B, Ghazavi A, Mosayebi G. Increased expression of CD8 marker on T-cells in COVID-19 patients. Blood Cells Mol Dis. 2020;83: 102437.","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"1476_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-018-0990-5","volume":"18","author":"SS Aly","year":"2018","unstructured":"Aly SS, Fayed HM, Ismail AM, Abdel Hakeem GL. Assessment of peripheral blood lymphocyte subsets in children with iron deficiency anemia. BMC Pediatr. 2018;18(1):1\u20136.","journal-title":"BMC Pediatr"},{"issue":"5","key":"1476_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2019.101477","volume":"33","author":"T Ot\u00f3n","year":"2019","unstructured":"Ot\u00f3n T, Carmona L. The epidemiology of established rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2019;33(5): 101477.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"1476_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3904\/kjim.2021.363","volume":"37","author":"J-W Kim","year":"2022","unstructured":"Kim J-W, Choe J-Y, Park S-H. Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease. Korean J Intern Med. 2022;37(1):13.","journal-title":"Korean J Intern Med"},{"issue":"22","key":"1476_CR31","doi-asserted-by":"publisher","first-page":"10252","DOI":"10.18632\/aging.102453","volume":"11","author":"Y Han","year":"2019","unstructured":"Han Y, Yuan F, Deng C, He F, Zhang Y, Shen H, Chen Z, Qian L. Metformin decreases LPS-induced inflammatory response in rabbit annulus fibrosus stem\/progenitor cells by blocking HMGB1 release. Aging (Albany NY). 2019;11(22):10252.","journal-title":"Aging (Albany NY)"},{"key":"1476_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2021.06.003","author":"B Sun","year":"2021","unstructured":"Sun B, Ying S, Ma Q, Li H, Li J, Song J. Metformin ameliorates HMGB1-mediated oxidative stress through mTOR pathway in experimental periodontitis. Genes Dis. 2021. https:\/\/doi.org\/10.1016\/j.gendis.2021.06.003.","journal-title":"Genes Dis"},{"issue":"6","key":"1476_CR33","first-page":"5366","volume":"16","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhang X, Zhuang L, Xu C, Li T, Zhang G, Liu Y. Decreased regulatory T-cell frequency and interleukin-35 levels in patients with rheumatoid arthritis. Exp Ther Med. 2018;16(6):5366\u201372.","journal-title":"Exp Ther Med"},{"issue":"1","key":"1476_CR34","first-page":"92","volume":"10","author":"MR Jafari-Nakhjavani","year":"2019","unstructured":"Jafari-Nakhjavani MR, Ghorbanihaghjo A, Bagherzadeh-Nobari B, Malek-Mahdavi A, Rashtchizadeh N. Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis. Caspian J Intern Med. 2019;10(1):92.","journal-title":"Caspian J Intern Med"},{"key":"1476_CR35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/jehp.jehp_390_18","volume":"8","author":"N Soleimani","year":"2019","unstructured":"Soleimani N, Hosseinzadeh M, Habibagahi Z. Value of serum glucose-6-phosphate isomerase in patients with rheumatoid arthritis and correlation with disease activity: a case\u2013control study. J Educ Health Promot. 2019;8:125.","journal-title":"J Educ Health Promot"},{"issue":"9","key":"1476_CR36","first-page":"794","volume":"34","author":"R Wang","year":"2018","unstructured":"Wang R, Wang P. HMGB1 promotes myocardial ischemic injury and regulates the proportion of CD4+, CD8+ T cells and Th17 cells in spleen through TLR4. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018;34(9):794\u20139.","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"1","key":"1476_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1080\/26895293.2020.1734671","volume":"13","author":"K Xin","year":"2020","unstructured":"Xin K, Sun J, Liu P, Ge J, Leng C, Pang F. Expression and significance of HMGB1 in patients with sepsis and effects on prognosis. All Life. 2020;13(1):164\u201370.","journal-title":"All Life"},{"issue":"2","key":"1476_CR38","first-page":"204","volume":"7","author":"M Amini","year":"2019","unstructured":"Amini M, Pakdaman A, Shapoori S, Mosayebi G. High mobility group box-1 (HMGB1) protein as a biomarker for acute cholecystitis. Rep Biochem Mol Biol. 2019;7(2):204.","journal-title":"Rep Biochem Mol Biol"},{"issue":"9","key":"1476_CR39","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41423-020-0492-x","volume":"17","author":"L Chen","year":"2020","unstructured":"Chen L, Long X, Xu Q, Tan J, Wang G, Cao Y, Wei J, Luo H, Zhu H, Huang L. Elevated serum levels of S100A8\/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients. Cell Mol Immunol. 2020;17(9):992\u20134.","journal-title":"Cell Mol Immunol"},{"key":"1476_CR40","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.12659\/MSM.910099","volume":"24","author":"N Gao","year":"2018","unstructured":"Gao N, Yan C, Zhang G. Changes of serum procalcitonin (PCT), C-reactive protein (CRP), interleukin-17 (IL-17), interleukin-6 (IL-6), high mobility group protein-B1 (HMGB1) and D-dimer in patients with severe acute pancreatitis treated with continuous renal replacement therapy (CRRT) and its clinical significance. Med Sci Monit. 2018;24:5881.","journal-title":"Med Sci Monit"},{"key":"1476_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118164","volume":"258","author":"I Kaur","year":"2020","unstructured":"Kaur I, Behl T, Bungau S, Kumar A, Mehta V, Setia D, Uddin MS, Zengin G, Aleya L, Arora S. Exploring the therapeutic promise of targeting HMGB1 in rheumatoid arthritis. Life Sci. 2020;258: 118164.","journal-title":"Life Sci"},{"issue":"7","key":"1476_CR42","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3899\/jrheum.110091","volume":"38","author":"R Pullerits","year":"2011","unstructured":"Pullerits R, Urbonaviciute V, Voll RE, Forsblad-D\u2019Elia H, Carlsten H. Serum levels of HMGB1 in postmenopausal patients with rheumatoid arthritis: associations with proinflammatory cytokines, acute-phase reactants, and clinical disease characteristics. J Rheumatol. 2011;38(7):1523\u20135.","journal-title":"J Rheumatol"},{"issue":"4","key":"1476_CR43","first-page":"463","volume":"42","author":"A Ozturk","year":"2020","unstructured":"Ozturk A, Bilgetekin YG, Atilla HA, Emlek M, Ersan O, \u00c7etin E, Yalcindag A. High mobility group box-1 in patients with bacterial septic arthritis of the knee: a controlled prospective study. Erciyes Med J. 2020;42(4):463\u20138.","journal-title":"Erciyes Med J"}],"updated-by":[{"DOI":"10.1186\/s40001-023-01573-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000}}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01476-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01476-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01476-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:58:08Z","timestamp":1730509088000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01476-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1476"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01476-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"1 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s40001-023-01573-x","URL":"https:\/\/doi.org\/10.1186\/s40001-023-01573-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients signed the informed consent. The present study obeyed the Declaration of Helsinki. Study approval was obtained by the ethical committee of Human Provincial People\u2019s Hospital [2023]-59.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"512"}}